If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,344.00
Ask: 12,346.00
Change: 68.00 (0.55%)
Spread: 2.00 (0.016%)
Open: 12,268.00
High: 12,388.00
Low: 12,256.00
Prev. Close: 12,264.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Spain limits AstraZeneca coronavirus vaccine to over 60-year olds

Wed, 07th Apr 2021 23:14

(Recasts to focus on AstraZeneca)

MADRID, April 7 (Reuters) - Spain will only give
AstraZeneca's coronavirus vaccine to people over 60 years old
after European and British regulators found a potential link
between the shot and rare brain blood clots.

"The vaccination strategy is changing and from tomorrow only
over 60-year-olds will be vaccinated with AstraZeneca," Health
Minister Carolina Darias told a news conference late on
Wednesday following a meeting of regional health chiefs.

Darias said a decision would be taken on Thursday on whether
to administer the second round of the vaccine to people who had
already received their first dose.

The European Medicines Agency announced earlier it had
reports of 169 cases of the rare clotting disorder out of 34
million doses administered within Europe, roughly one for every
100,000 people under 60 vaccinated. Most occurred in women under
60 and within two weeks of injection. [nL1N2M01J1

Maria Jesus Lamas, director of Spain's drug regulator, said
that number was higher than expected, though very small:
"Despite the rarity of these side effects, the modification to
the technical guidance is important," Lamas said.

A summit of European Union health ministers failed to agree
on common guidance for the vaccine and the EMA said countries
should set their own regulations.

Spain's decision follows Italy recommending the shot only
for those over 60 and Britain said people under 30 should get an
alternative.

People lining up for a shot in Madrid earlier on Wednesday
vented frustration at constantly changing guidance for the
vaccine, which is subject to a patchwork of different rules
governing its use.

"Today has been a very distressing day because of all the
news coming from the European Medicines Agency," said Carmen
Ruiz after coming out of Atletico Madrid's Wanda football
stadium, now converted into a vaccine centre.

Though Spain is faring better than neighbouring France,
where rampant infections have pushed hospital admittance rates
to near five-month highs, the daily caseload has been increasing
for three weeks.

The health ministry registered 8,788 new cases, bringing the
total to 3.33 million. The death toll rose by 126 to 76,037.

Wary that increased social contact over Easter could trigger
a full-blown fourth wave, authorities in Catalonia, the Basque
Country and Aragon imposed fresh restrictions on movement.

(Reporting by Clara-Laeila Laudette, Guillermo Martinez, Elena
Rodriguez, Nathan Allen and Joan Faus, editing by Andrei Khalip
and Grant McCool)

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.